Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients

Abstract

These results indicate that the inflammatory markers, mGPS and LMR are independent prognostic factors for predicting overall survival in relapsed/refractory mCRC patients.